Obsidian Therapeutics, Inc. (OBX) stock
Close on Nov 20, 2026Market cap $741.28MP/E –Yield –
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Sep 30, 2026
Valuation
- Market cap
- $741.28M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 2.31
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Book value per share
- $7.81
- Diluted shares
- 41M
Trading
- Previous close
- $12.15
- Open
- $12.01
- Day's range
- $11.76 – $12.30
- Volume
- 336,498
- Average volume (20 days)
- 598,829
- RSI (14 days)
- 43.2
- Relative volume
- 0.81×
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 20, 2026. The S&P 500 is measured by the SPY fund.
| Period | OBX | S&P 500 | Difference | OBX per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -9.4% | -10.3% | +0.9 pts | ||
| 3 months | -40.6% | -9.3% | −31.2 pts |
Two years at a glance
Fiscal years 2024 to 2025, USD
Press releases
Releases Obsidian Therapeutics filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
Obsidian Therapeutics stock: common questions
What is Obsidian Therapeutics's stock price?
OBX closed at $12.00 on Nov 20, 2026, down 1.23% on the day.
What is Obsidian Therapeutics's market cap?
Obsidian Therapeutics was worth $741.28M at the close on Nov 20, 2026: the share price times the diluted shares outstanding.
Does Obsidian Therapeutics pay a dividend?
No. Obsidian Therapeutics has not paid a cash dividend over the last twelve months.
How many OBX shares are sold short?
1M shares were sold short at the latest FINRA report, 1.92% of the float, or 3.9 days of average trading volume.
Who are Obsidian Therapeutics's competitors?
Companies most similar to Obsidian Therapeutics by business, industry and size include LLY, JNJ, ABBV, MRK, AZN.
See a number that looks wrong?